Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Cited by (1,001)

Items 901–1,000 of 1,001

1. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
   Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie‐Ève Hamelin, Deirdre McCormack, Patrice Savard, Yves Longtin, Matthew Pellan Cheng et al. · 2022 · Frontiers in Immunology
2. Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
   Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas, Dimitra T. Stefanou, Konstantinos Syrigos, George N. Pavlakis, Vassilis L. Souliotis · 2022 · Vaccines
3. Architecture of the SARS-CoV-2-specific T cell repertoire
   Ksenia V. Zornikova, Saveliy Andreevich Sheetikov, Alexander Yu Rusinov, Rustam N. Iskhakov, Боголюбова Аполлинария Васильевна · 2023 · Frontiers in Immunology
4. Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency
   Cliodhna E. Murray, C. O’Brien, S. Alamin, Stuart Hendricken Phelan, R. Argue, Rachel Kiersey, M. Gardiner, A. Naughton, E. Keogh, P. Holmes et al. · 2023 · Frontiers in Immunology
5. Human CCR6+ Th Cells Show Both an Extended Stable Gradient of Th17 Activity and Imprinted Plasticity
   Satya P. Singh, Farhat Parween, Nithin V. Edara, Hongwei H. Zhang, Jinguo Chen, Francisco A. Otaizo-Carrasquero, Debby Cheng, Nicole A. Oppenheim, Amy Ransier, Wenjun Zhu et al. · 2023 · The Journal of Immunology
6. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
   Aaruni Khanolkar · 2021 · Cells
7. Overcoming STING Agonists Barriers: Peptide, Protein, and Biomembrane‐based Biocompatible Delivery Strategies
   Yongfang Zheng, Jun Wu · 2022 · Chemistry - An Asian Journal
8. Limited Recognition of Highly Conserved Regions of SARS-CoV-2
   Srividhya Swaminathan, Katie E. Lineburg, George R. Ambalathingal, Pauline Crooks, Emma J. Grant, Sonali Vishwa Mohan, Jyothy Raju, Archana Panikkar, Laëtitia Le Texier, Zhen Wei Marcus Tong et al. · 2022 · Microbiology Spectrum
9. Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities
   Chun-Hsiang Chiu, Yu-Hsiu Chang, Feng‐Yee Chang, Yi‐Jen Hung, Ching‐Len Liao, Kuo‐Chou Chiu, Pei-Ling Tsai, Tien-Wei Chang, Li-Chen Yen · 2022 · Frontiers in Cellular and Infection Microbiology
10. Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
    Juntao Yin, Yangyang Chen, Yang Li, Xingwang Zhang, Chaoyang Wang · 2022 · Human Vaccines & Immunotherapeutics
11. Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
    Jolene Yin Ling Fu, Muhammad Harith Pukhari, Maria Kahar Bador, I‐Ching Sam, Yoke Fun Chan · 2023 · Viruses
12. CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
    Isabel Neale, Mohammad Ali, Barbara Kronsteiner, Stéphanie Longet, Priyanka Abraham, Alexandra S. Deeks, Anthony Brown, Shona C. Moore, Lizzie Stafford, Susan L. Dobson et al. · 2023 · mBio
13. Crosstalk between Platelets and SARS-CoV-2: Implications in Thrombo-Inflammatory Complications in COVID-19
    Junyi Zhao, Xiafan Xu, Yifei Gao, Yijing Yu, Conglei Li · 2023 · International Journal of Molecular Sciences
14. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against SARS-CoV-2 in People Living with HIV (PLWH) Receiving Antiretroviral Therapy (ART) According with Current CD4 T-Lymphocyte Count
    Andrea Antinori, Stefania Cicalini, Silvia Meschi, Veronica Bordoni, Patrizia Lorenzini, Alessandra Vergori, Simone Lanini, Lidya De Pascale, Giulia Matusali, Davide Mariotti et al. · 2021 · SSRN Electronic Journal
15. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · Research Square
16. Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
    Alexander Muik, Bonny Gaby Lui, Huitian Diao, Yunguan Fu, Maren Bacher, Aras Toker, Jessica Grosser, Orkun Ozhelvaci, Katharina Grikscheit, Sebastian Hoehl et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
17. Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
    Abdulfattah Adekunle Onifade, Adeola Fowotade, Sheu Kadiri Rahamon, Victory Fabian Edem, Surajudeen Adebayo Yaqub, Olatunji K. Akande, Olatunbosun Ganiyu Arinola · 2023 · PLoS ONE
18. Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
    Rupsha Fraser, Aurelio Orta Resendiz, David Harold Dockrell, Michaela C. Müller-Trutwin, Alexander Mazein · 2023 · European Respiratory Review
19. A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses
    S. M. Shahjahan Miah, Sandra Lélias, Andrés H. Gutiérrez, Mitchell McAllister, Christine Boyle, Lenny Moise, Anne Searls De Groot · 2023 · Frontiers in Immunology
20. Age‐related transcript changes in type I interferon signaling in children and adolescents with long COVID
    Matteo Fracella, Enrica Mancino, Raffaella Nenna, Chiara Virgillito, Federica Frasca, Alessandra D’Auria, Leonardo Sorrentino, Laura Petrarca, Domenico Paolo La Regina, Luigi Matera et al. · 2024 · European Journal of Immunology
21. Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine
    Navid Dashti, Forough Golsaz‐Shirazi, Haleh Soltanghoraee, Amir‐Hassan Zarnani, Mehdi Mohammadi, Danyal Imani, Mahmood Jeddi‐Tehrani, Mohammad Mehdi Amiri, Fazel Shokri · 2024 · European Journal of Microbiology and Immunology
22. Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
    Keita Kawashiro, Rigel Suzuki, Takuto Nogimori, Shuhei Tsujino, Naoya Iwahara, Takayuki Hirose, Kazufumi Okada, Takuya Yamamoto, Takasuke Fukuhara, Kiyohiko Hotta et al. · 2024 · Scientific Reports
23. Activation-Induced Marker Assay to Identify and Isolate HCV-Specific T Cells for Single-Cell RNA-Seq Analysis
    Mohamed Eisa, Nicol Flores, Omar Khedr, Elsa Gomez‐Escobar, Nathalie Bédard, Nourtan F. Abdeltawab, Julie Bruneau, Arash Grakoui, Naglaa H. Shoukry · 2024 · Viruses
24. Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells
    Laury Nguema, Florence Picard, Marwa El Hajj, Léa Dupaty, Craig W. Fenwick, Sylvain Cardinaud, Aurélie Wiedemann, Giuseppe Pantaleo, Sandra Zurawski, Mireille Centlivre et al. · 2024 · EBioMedicine
25. A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine
    Ismail Cem Yilmaz, Emre Mert İpekoğlu, Berfu Saraydar, Tugce Bildik, Aslı Gulce Bartan Aksoy, İrem Evcili, Nilsu Turay, Naz Sürücü, Artun Bulbul, Nese Guvencli et al. · 2025 · Vaccine
26. mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
    Philip Samaan, Chapin S. Korosec, Patrick Budylowski, Serena Chau, Adrian Pasculescu, Freda Qi, Melanie Delgado-Brand, Tulunay R. Tursun, Geneviève Mailhot, Roya Monica Dayam et al. · 2025 · Journal of Virology
27. Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
    Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, Moshe Levi, Avi Z. Rosenberg · 2025 · Frontiers in Immunology
28. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunity and Reinfection
    Jennifer M. Dan, Sanjay R. Mehta · 2021 · Clinical Infectious Diseases
29. Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Zaid Alhinai, Nagi Elsidig · 2021 · International Journal of Infectious Diseases
30. Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital
    Cristina S. Costa, Gitana Scozzari, Enrica Migliore, Claudia Galassi, Giovannino Ciccone, Guido Ricciardelli, Antonio Scarmozzino, Lorenzo Angelone, Paola Cassoni, Rossana Cavallo et al. · 2022 · Vaccines
31. Success of nano-vaccines against COVID-19: a transformation in nanomedicine
    M. Sarangi, S. Padhi, G. Rath, S. S. Nanda, Dong-Kee Yi · 2022 · Expert Review of Vaccines
32. Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
    Jonathon M. Monroe, Iana H. Haralambieva, Nathaniel D. Warner, Diane E. Grill, Huy Quang Quach, Richard B. Kennedy · 2022 · Heliyon
33. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice
    Gabriela Chávez‐Calvillo, Whitney Burns, Liliana Garcia, Gerelyn Henry, Anthony Biancofiori, Albert George, Ciera Duffy, Justin Chu, Morgan Sides, Melissa Muñoz et al. · 2022 · Viruses
34. The origins of new SARS-COV-2 variants in immunocompromised individuals
    Anna C. Riddell, Teresa Cutiño‐Moguel · 2023 · Current Opinion in HIV and AIDS
35. T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets
    Alexandre Eduardo Nowill, Manuel Caruso, Pedro Otavio de Campos-Lima · 2023 · Frontiers in Immunology
36. Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother
    Nilufar R. Gashimova, Liudmila L. Pankratyeva, Victoria O. Bitsadze, Jamilya Kh. Khizroeva, Maria V. Tretyakova, Kristina N. Grigoreva, Valentina I. Tsibizova, Jean‐Christophe Gris, N.D. Degtyareva, F. E. Yakubova et al. · 2023 · Journal of Clinical Medicine
37. A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
    Stephen Boulton, Joanna Poutou, Rida Gill, Nouf Alluqmani, Xiaohong He, Ragunath Singaravelu, Mathieu J. F. Crupi, Julia Petryk, Bradley Austin, Leonard Angka et al. · 2023 · Molecular Therapy — Methods & Clinical Development
38. Essential role for Batf3-dependent dendritic cells in regulating CD8 T-cell response during SARS-CoV-2 infection
    Liat Bar‐On, Hani Dekel Jaoui, Moshe Aftalion, Theodor Chitlaru, Noam Erez A · 2023 · PLoS ONE
39. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
    Jet van den Dijssel, Mariël C Duurland, Veronique A. L. Konijn, Laura Y. L. Kummer, Ruth R. Hagen, Lisan H Kuijper, Luuk Wieske, Koos P J van Dam, Eileen W Stalman, Maurice Steenhuis et al. · 2024 · Journal of Autoimmunity
40. What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders
    E. Maggi, B. Azzarone, G. Canonica, L. Moretta · 2021 · Allergy. European Journal of Allergy and Clinical Immunology
41. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
    Yi‐Hao Chan, Barnaby Edward Young, Siew‐Wai Fong, Ying Ding, Yun Shan Goh, Rhonda Sin‐Ling Chee, Seow Yen Tan, Shirin Kalimuddin, Paul Anantharajah Tambyah, Yee‐Sin Leo et al. · 2021 · Frontiers in Immunology
42. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
    Li Min, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, Zhenchuan Wu, Xiangyin Kong, Yufei Zhu, Xianchao Zhou et al. · 2022 · Journal of Allergy and Clinical Immunology
43. An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
    Yukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, Kazuhito Miyazaki, Koji Okudela, Yoko Tateishi, Hiroyuki Hayashi, Ai Kawana‐Tachikawa, Hiromichi Iwashita, Kazuho Maeda et al. · 2022 · International Journal of Infectious Diseases
44. SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination
    Simone Vespa, Pasquale Simeone, Giulia Catitti, Davide Buca, Domenico De Bellis, Laura Pierdomenico, Damiana Pieragostino, Ilaria Cicalini, Piero Del Boccio, Luca Natale et al. · 2022 · International Journal of Molecular Sciences
45. Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
    Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, Mohammad Darvishi, Saeid Fathi, Mohammad Javanbakht, Sepehr Shafiee, Reza Akhavan‐Sigari · 2022 · Frontiers in Immunology
46. Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
    Matthew D. Resch, Ke Wen, Ryan Mazboudi, Hannah Mulhall Maasz, Mirjana Persaud, Kaitlyn Garvey, Leslie Gallardo, Paul Gottlieb, Aleksandra Alimova, Reza Khayat et al. · 2022 · Vaccines
47. Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection
    Larraitz Aragón, Andrea Iribarren-López, Ainhoa Alberro, Leire Iparraguirre, Miguel Von Wichmann, José María Marimón, Nagore Saiz-Calderon, Julia Agudo, M. Isabel Gálvez, M. Carmen Cipitria et al. · 2023 · Frontiers in Aging
48. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital
    Ayanda Trevor Mnguni, Denzil Schietekat, Nabilah Ebrahim, Nawhaal Sonday, Nicholas Boliter, Neshaad Schrueder, Shiraaz Gabriels, Lovemore Nyasha Sigwadhi, Annalise E. Zemlin, Zivanai Cuthbert Chapanduka et al. · 2023 · BMC Infectious Diseases
49. Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
    Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Tiantian Ma et al. · 2023 · Emerging Microbes & Infections
50. Potential global impact of the N501Y mutation on MHC-II presentation and immune escape
    Andrea Castro, Hannah K. Carter, Maurizio Zanetti · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
51. Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction
    S. Rouhani, Jonathan A. Trujillo, A. Pyzer, Jovian Yu, Jessica L. Fessler, Alexandra Cabanov, Emily F. Higgs, Kyle R Cron, Y. Zha, Yihao Lu et al. · 2021 · medRxiv
52. Сorrelation between age and the intensity of the post-vaccination humoral immune response in individuals passed COVID-19
    A.I. Andreev, Igor V. Andreev, Ksenia O. Nechay, Daria R. Esaulova, O.S. Baklakova, V.I. Vecherko, Igor P. Shilovskiy, И.А. Кофиади, Г.О. Гудима, Alexandr I. Martynov et al. · 2022 · Immunologiya
53. The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo
    Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, Cali Sweitzer, Anna-Nicole Bosco, Amy C Sherman, Lindsey Robert Baden, Elena Morrocchi, Guzman Sánchez‐Schmitz, Paolo Palma et al. · 2024 · iScience
54. COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation
    Javier Rodríguez‐Ubreva, Josep Calafell-Segura, Celia Lourdes Calvillo, Baerbel Keller, Laura Ciudad, Louis‐François Handfield, Carlos de la Calle‐Fabregat, Gerard Godoy‐Tena, Eduardo Andrés‐León, Regina Hoo et al. · 2024 · Nature Communications
55. The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells
    Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori, Chen Liu, Atena Nemati, Nicholas Rozza, Ami Grunbaum, Richard B. Kremer, Catalin Milhalcioiu, Denis‐Claude Roy et al. · 2025 · Communications Biology
56. Aging and inflammation limit the induction of SARS-CoV-2–specific CD8+ T cell responses in severe COVID-19
    Gaëlle Autaa, Laura Papagno, Takuto Nogimori, Andréa Boizard-Moracchini, Daniil A. Korenkov, Maeva Roy, Koichiro Suzuki, Yuji Masuta, Eoghann White, Sian Llewellyn‐Lacey et al. · 2025 · JCI Insight
57. Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains
    Maja Stanojevic, Ashley E. Geiger, Brita Ostermeier, Danielle K. Sohai, Christopher A. Lazarski, Haili Lang, Mariah A. Jensen-Wachspress, Kathleen Webber, Peter D. Burbelo, Jeffrey I. Cohen et al. · 2021 · Cytotherapy
58. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient
    Changchun Lai, Xinglong Liu, Qihong Yan, Hualiang Lv, Lei Zhou, Longbo Hu, Yong Cai, Guoqiang Wang, Yufeng Chen, Renjie Chai et al. · 2021 · Frontiers in Immunology
59. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
    Michele Maio, Michael Lahn, Anna Maria Di Giacomo, Alessia Covre, Luana Calabrò, Ramy A. Ibrahim, Bernard A. Fox, The Siena Think Tank, Sergio Abrignani, Paola Allavena et al. · 2021 · Journal of Experimental & Clinical Cancer Research
60. Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021
    Francesca Colavita, Silvia Meschi, Cesare Ernesto Maria Gruber, Martina Rueca, Francesco Vairo, Giulia Matusali, Daniele Lapa, Emanuela Giombini, Gabriella De Carli, Martina Spaziante et al. · 2022 · Frontiers in Medicine
61. Antigen–Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD
    Kit-Man Fung, S. Lai, Tzu-Lu Lin, T. Tseng · 2022 · Frontiers in Molecular Biosciences
62. Efficacy and Safety of Peptide Vaccine in Prevention of SARS-CoV-2 Infection: Prospective Study among Healthcare Professionals
    Leyla Seymurovna Namazova-Baranova, Мarina V. Fedoseenko, Firuza Ch. Shakhtakhtinskaya, Tatiana A. Kaliuzhnaia, Margarita А. Soloshenko, Толстова Светлана Васильевна, Сельвян Аревалуис Месроповна, Tatiana E. Privalova, Тимошкова Снежана Дмитриевна, Albina A. Melnikova et al. · 2022 · Вопросы современной педиатрии
63. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
    Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, Rosy Manuele, Fabrizio Puglisi, Andrea Maugeri, Alessandro Barbato, Anna Maria Triolo, Cesarina Giallongo, Daniele Tibullo et al. · 2022 · Scientific Reports
64. Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
    Sónia André, Marne Azarias-da-Silva, Morgane Picard, Aurélie Alleaume‐Butaux, Lucy Kundura, Renaud Cezar, Calaiselvy Soudaramourty, André Santa Cruz, Ana Mendes‐Frias, Alexandre Carvalho et al. · 2022 · Cell Death and Disease
65. Single‐cell transcriptome atlas reveals protective characteristics of COVID‐19 mRNA vaccine
    Yong Cheng Tan, Shuaiyao Lu, Bo Wang, Xuewen Duan, Yunkai Zhang, Xiaozhong Peng, Hangwen Li, Ang Lin, Zhenzhen Zhan, Xingguang Liu · 2022 · Journal of Medical Virology
66. The bullwhip effect, T-cell telomeres, and SARS-CoV-2
    Abraham Aviv · 2022 · The Lancet Healthy Longevity
67. The m7G Modification Level and Immune Infiltration Characteristics in Patients with COVID-19
    Lingling Lu, Jiaolong Zheng, Bang Liu, Haicong Wu, Jiaofeng Huang, Liqing Wu, Dongliang Li · 2022 · Journal of Multidisciplinary Healthcare
68. Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
    Celia Andrés, José Manuel Pérez de la Lastra, Celia Juan, Francisco J. Plou, Eduardo Pérez‐Lebeña · 2023 · Vaccines
69. Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
    Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Julie Røkke Osen, Viktoriia Chaban, Katrine Persgård Lund, Lisa Tietze, Trung The Tran, Fridtjof Lund‐Johansen, Hassen Kared et al. · 2023 · Frontiers in Immunology
70. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19
    Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama‐Hosoya, Shoji Miki, Kazuo Yamashita, Mark S. de Souza, Tetsuro Matano, Ai Kawana‐Tachikawa · 2023 · Microbiology Spectrum
71. Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity
    Vanessa Silva‐Moraes, Aisha Hegab Souquette, Giuseppe Andrea Sautto, Ida Paciello, Giada Antonelli, Emanuele Andreano, Rino Rappuoli, Andréa Teixeira‐Carvalho, Ted M. Ross · 2023 · ImmunoHorizons
72. Humoral and cellular immunity against diverse SARS-CoV-2 variants
    Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
73. Memory T Cells Discrepancies in COVID-19 Patients
    Hajir AlSaihati, Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, Sabry Younis Mahmoud, Eman S. Farrag, Taha I. A. Mohamed, Samah M. Fathy, Mohamed E. Elnosary, Ali Sobhy et al. · 2023 · Microorganisms
74. The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study
    Yanli Kang, Shifa Lu, Ruifang Zhong, Jianbin You, Jiahao Chen, Ling Li, Rongbin Huang, Yanyan Xie, Falin Chen, Jinhua Chen et al. · 2023 · Heliyon
75. General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)
    Алпатова Наталья Александровна, Ж. И. Авдеева, Лысикова Светлана Леонидовна, O. V. Golovinskaya, Гайдерова Лидия Александровна · 2020 · Biological Products Prevention Diagnosis Treatment
76. Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
    Akitoshi Ueno, Hitoshi Kawasuji, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Mayuko Saito, Seiji Yamashiro, Yoshitomo Morinaga, Kazunori Oishi, Yoshihiro Yamamoto · 2021 · Journal of Infection and Chemotherapy
77. Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses
    Johannes Martinus Dijkstra, Aaron P. Frenette, Brian Dixon · 2021 · F1000Research
78. Development of neutralizing antibody responses against SARS‐CoV‐2 in COVID‐19 patients
    Marı́a Teresa Valenzuela, Cinthya Urquidi, N. Rodríguez, Luis D. Castillo, Jorge Onrubia Fernández, Eugenio Ramírez V · 2021 · Journal of Medical Virology
79. An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19
    S. M. Monzavi, M. Naderi, N. Ahmadbeigi, A. Kajbafzadeh, S. Muhammadnejad · 2021 · Cellular Immunology
80. Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
    B. Olea, E. Albert, I. Torres, P. Amat, M. J. Remigia, Roberto Gozalbo-Rovira, J. Rodríguez-Díaz, J. Buesa, M. Blasco, J. Redón et al. · 2021 · medRxiv
81. Impairment of T cells' antiviral and anti-inflammation immunities may be critical to death from COVID-19
    Luhao Zhang, Rong Li, Gang Song, Gregory D. Scholes, Zhen-Su She · 2021 · Royal Society Open Science
82. Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants
    Syed Faraz Ahmed, Muhammad Saqib Sohail, Ahmed Abdul Quadeer, Matthew R. McKay · 2022 · Vaccines
83. Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO)
    Sabrina Jotschke, Susann Schulze, Nadja Jaekel, Beatrice Ludwig‐Kraus, Robby Engelmann, Frank Bernhard Kraus, Christina Zahn, Nicole Nedlitz, Gabriele Prange‐Krex, Johannes Mohm et al. · 2022 · Cancers
84. Implications of helminth immunomodulation on COVID-19 co-infections
    Nathalie Chacón, Leonor Chacín‐Bonilla, M. Italo · 2021 · Life Research
85. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection
    Mohammed A. H. Farouq, Reinaldo Acevedo, Valerie Anne Ferro, Paul Alexander Mulheran, Mohammed M. Al Qaraghuli · 2022 · International Journal of Molecular Sciences
86. Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis?
    Sunil Nagpal, Nishal Kumar Pinna, Namrata Pant, Rohan P. Singh, Divyanshu Srivastava, Sharmila S. Mande · 2022 · Journal of Molecular Biology
87. Individuals with obesity who survive SARS‐CoV ‐2 infection have preserved antigen‐specific T cell frequencies
    Neil E. Wrigley Kelly, Grace Kenny, Féaron C. Cassidy, A. Léon, Conor De Barra, Patrick W. G. Mallon, Andrew E. Hogan, Donal Brendan O'Shea · 2022 · Obesity
88. Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
    Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Xiaojian Zhu, Zhengming Zhu, Qinrong Wu, Rongfa Yuan · 2022 · Frontiers in Immunology
89. Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development
    Lin Feng, Xiaoyuan Lin, Beibei Fu, Yan Xiong, Mohamed Y. Zaky, Haibo Wu · 2023 · Life Sciences
90. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
    Mithil K. Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S. May, Marcus R. Pereira et al. · 2023 · Frontiers in Immunology
91. Deadly COVID-19 among the elderly: Innate immune memory helping those most in need
    Yahya Sohrabi, Holger Reinecke, Leo A. B. Joosten, Mihai Gheorghe Netea · 2021 · Med
92. A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes
    David A. Potter, Alexandra Thomas, Hope S. Rugo · 2021 · Clinical Cancer Research
93. Intranasal self-amplifying RNA SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
    Madeleine F. Jennewein, Michael D. Schultz, Samuel Beaver, Peter Battisti, Julie Bakken, Derek Hanson, Jobaida Akther, Fen Zhou, Raodoh Mohamath, Jasneet Singh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
94. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
    Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, Dillon R. Flebbe, Anna Mychalowych, Evan Lamb, Meredith E. Davis-Gardner, Matthew R. Burnett, Leonid Serebryannyy, Bob C. Lin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
95. A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
    Swayam Prakash, Nisha Rajeswari Dhanushkodi, Mahmoud Singer, Afshana Quadiri, Latifa Zayou, Hawa Vahed, Pierre-Gregoire A. Coulon, Izabela Coimbra Ibraim, Christine Tafoya, Lauren Hitchcock et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
96. Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies
    Simon B. Gressens, Aurélie Wiedemann, Marie Déchenaud, Jehan Dupuis, Sébastien Gallien, Giovanna Melica, Corinne Haïoun, François Lemonnier, Yves Lévy · 2023 · Vaccine
97. Relationship between Vitamin D and Immunity in Older People with COVID-19
    Fulvio Lauretani, Marco Salvi, Irene Zucchini, Crescenzo Testa, Chiara Cattabiani, Arianna Arisi, Marcello Giuseppe Maggio · 2023 · International Journal of Environmental Research and Public Health
98. Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects
    Yizhao Chen, Chong Liu, Yilong Fang, Weile Chen, Jiaqi Qiu, Mengjuan Zhu, Wei Wei, Jiajie Tu · 2024 · Biochemical Pharmacology
99. Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
    Xianghui Li, Yabo Zhang, Libing He, Jiangzhe Si, Shuai Qiu, Yuhua He, Jiacun Wei, Zhili Wang, Longxiang Xie, Yanzhang Li et al. · 2022 · International Journal of Biological Sciences
100. Combined Effects of Exercise Training and Nutritional Supplementation in Cancer Patients in the Context of the COVID-19: A Perspective Study
     Mahdieh Molanouri Shamsi, Alieh Vahed, Amir Hossein Ahmadi Hekmatikar, Katsuhiko Suzuki · 2022 · Frontiers in Nutrition